These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 6419766

  • 1. Vaccine and serum-mediated protection against brucella infection of mouse placenta.
    Bosseray N.
    Br J Exp Pathol; 1983 Dec; 64(6):617-25. PubMed ID: 6419766
    [Abstract] [Full Text] [Related]

  • 2. Kinetics of placental colonization of mice inoculated intravenously with Brucella abortus at day 15 of pregnancy.
    Bosseray N.
    Br J Exp Pathol; 1983 Dec; 64(6):612-6. PubMed ID: 6419765
    [Abstract] [Full Text] [Related]

  • 3. Colonization of mouse placentas by Brucella abortus inoculated during pregnancy.
    Bosseray N.
    Br J Exp Pathol; 1980 Aug; 61(4):361-8. PubMed ID: 6775668
    [Abstract] [Full Text] [Related]

  • 4. Serum- and cell-mediated immune protection of mouse placenta and fetus against a Brucella abortus challenge: expression of barrier effect of placenta.
    Bosseray N, Plommet M.
    Placenta; 1988 Aug; 9(1):65-79. PubMed ID: 3129708
    [Abstract] [Full Text] [Related]

  • 5. [Anti-Brucella immunity transferred by immune serum and that transferred by splenic lymphocytes cannot be added].
    Plommet M, Hue I, Plommet AM.
    Ann Rech Vet; 1986 Aug; 17(2):169-75. PubMed ID: 3096188
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J.
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [Abstract] [Full Text] [Related]

  • 10. Comparison of protective efficacy of subcutaneous versus intranasal immunization of mice with a Brucella melitensis lipopolysaccharide subunit vaccine.
    Bhattacharjee AK, Izadjoo MJ, Zollinger WD, Nikolich MP, Hoover DL.
    Infect Immun; 2006 Oct; 74(10):5820-5. PubMed ID: 16988260
    [Abstract] [Full Text] [Related]

  • 11. Protection of mice against Brucella abortus infection by inoculation with monoclonal antibodies recognizing Brucella O-antigen.
    Phillips M, Deyoe BL, Canning PC.
    Am J Vet Res; 1989 Dec; 50(12):2158-61. PubMed ID: 2481994
    [Abstract] [Full Text] [Related]

  • 12. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, Godefroid J, Walravens K, Letesson JJ.
    Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
    [Abstract] [Full Text] [Related]

  • 13. Immunity to Brucella in mice vaccinated with a fraction (F8) or a killed vaccine (H38) with or without adjuvant. Level and duration of immunity in relation to dose of vaccine, recall injection and age of mice.
    Bosseray N.
    Br J Exp Pathol; 1978 Aug; 59(4):354-65. PubMed ID: 101226
    [Abstract] [Full Text] [Related]

  • 14. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
    Rajasekaran P, Surendran N, Seleem MN, Sriranganathan N, Schurig GG, Boyle SM.
    Vaccine; 2011 Apr 12; 29(17):3106-10. PubMed ID: 21376799
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of vaccination strategies against intranasal challenge with Brucella abortus in BALB/c mice.
    Surendran N, Sriranganathan N, Lawler H, Boyle SM, Hiltbold EM, Heid B, Zimmerman K, Witonsky SG.
    Vaccine; 2011 Mar 24; 29(15):2749-55. PubMed ID: 21316499
    [Abstract] [Full Text] [Related]

  • 16. Studies on the immune protection to murine experimental brucellosis conferred by Brucella fractions. I. Positive role of immune serum.
    Bascoul S, Cannat A, Huguet MF, Serre A.
    Immunology; 1978 Aug 24; 35(2):213-21. PubMed ID: 750371
    [Abstract] [Full Text] [Related]

  • 17. Immune serum-mediated effects on brucellosis evolution in mice.
    Plommet M, Plommet AM.
    Infect Immun; 1983 Jul 24; 41(1):97-105. PubMed ID: 6408007
    [Abstract] [Full Text] [Related]

  • 18. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice.
    Delpino MV, Estein SM, Fossati CA, Baldi PC, Cassataro J.
    Vaccine; 2007 Sep 17; 25(37-38):6721-9. PubMed ID: 17686554
    [Abstract] [Full Text] [Related]

  • 19. Protection of BALB/C mice against Brucella abortus 544 challenge by vaccination with combination of recombinant human serum albumin-l7/l12 (Brucella abortus ribosomal protein) and lipopolysaccharide.
    Pakzad I, Rezaee A, Rasaee MJ, Hossieni AZ, Tabbaraee B, Kazemnejad A.
    Roum Arch Microbiol Immunol; 2010 Sep 17; 69(1):5-12. PubMed ID: 21053778
    [Abstract] [Full Text] [Related]

  • 20. Immunity to Brucella abortus induced in mice by popliteal lymph node restricted strain 19 vaccination.
    Plommet M, Plommet AM.
    Ann Rech Vet; 1989 Sep 17; 20(1):73-81. PubMed ID: 2494933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.